'Pivotal Time For CROs': ICON CEO Cutler On Changing APAC Trial Trends

Dublin, Ireland-based ICON PLC witnessed a significant paradigm shift in clinical trials during the COVID-19 pandemic. Noted to be one of the top five contract research organizations in the world, CEO Steve Cutler recently pointed out a larger opportunity in decentralized trials that has the potential to be a “game changer” in the global pharma industry over the next five years.

In an interview, Cutler also refers to the need to accept new technologies by both clinical trial sites and regulators.